Lomerizine

Lomerizine

SCHEMBL29496366

COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 1.00
CHRM2 P08172 2/20 1.00
OPRK1 P41145 2/20 1.00
ADORA3 P0DMS8 1/20 1.00
CHRM1 P11229 1/20 1.00
DRD2 P14416 1/20 1.00
ADRA2B P18089 1/20 1.00
ADRA2C P18825 1/20 1.00
CNR1 P21554 1/20 1.00
SLC6A2 P23975 1/20 1.00
HTR2A P28223 1/20 1.00
HTR2C P28335 1/20 1.00
ADRA1A P35348 1/20 1.00
HRH1 P35367 1/20 1.00
OPRM1 P35372 1/20 1.00
DRD3 P35462 1/20 1.00
HTR2B P41595 1/20 1.00
HTT P42858 1/20 1.00
CACNA1B Q00975 1/20 1.00
SLC6A3 Q01959 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lomerizine SCHEMBL79390 1.00 LMNA (1.00) LMNACHRM2OPRK1ADORA3CHRM1
Lomerizine SCHEMBL29439945 0.99 LMNA (0.98) LMNACHRM2OPRK1ADORA3CHRM1
Lomerizine SCHEMBL404179 0.99 LMNA (0.98) LMNACHRM2OPRK1ADORA3CHRM1
Lomerizine SCHEMBL1153647 0.99 LMNA (0.98) LMNACHRM2OPRK1ADORA3CHRM1
Lomerizine SCHEMBL1650277 0.98 LMNA (0.95) LMNACHRM2OPRK1ADORA3CHRM1
SCHEMBL1152274 0.95 LMNA (0.91) LMNACHRM2OPRK1ADORA3CHRM1
Hydrochloric Acid SCHEMBL7324923 0.94 LMNA (0.89) LMNACHRM2OPRK1ADORA3CHRM1
Lomerizine SCHEMBL10731133 0.91 LMNA (0.82) LMNACHRM2OPRK1ADORA3CHRM1
Lomerizine SCHEMBL10731150 0.91 LMNA (0.82) LMNACHRM2OPRK1ADORA3CHRM1
SCHEMBL6138969 0.90 LMNA (0.81) LMNACHRM2OPRK1ADORA3CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3498297-B1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM STALICLA S A (CH) 2023-06-21 EP claimed
CN-115466561-B Casein modified water-based breathable coating and application thereof 上海欧畅新材料科技有限公司 2023-12-26 CN disclosed
CN-116507327-A Chewable formulations 礼蓝动物保健有限公司 2023-07-28 CN disclosed
EP-3498297-B1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM STALICLA S A (CH) 2023-06-21 EP disclosed
CN-115466561-A Casein modified water-based breathable coating and application thereof 上海欧畅新材料科技有限公司 2022-12-13 CN disclosed
US-11439627-B2 Pharmaceutical composition for the treatment of autism Stalicla S.A. (CH) 2022-09-13 US disclosed
EP-3984555-A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM Stalicla S.A. (CH) 2022-04-20 EP disclosed